Pioneer® Surgical Announces First Human Use of nanOss® Bioactive 3D (press release)
Pioneer Surgical today announces the first clinical use of nanOss Bioactive 3D, a three-dimensionally shaped addition to its flagship biologic bone graft product line, nanOss Bioactive. The new nanOss Bioactive 3D bone graft utilizes proprietary nanocrystalline hydroxyapatite as well as a collagen-based biopolymer to promote bone growth in the posterolateral spine.
Regarding Pioneer’s latest product introduction, Mr. Shane Ray, General Manager – Biologics for Pioneer stated, “We are extremely excited to start the clinical phase of nanOss Bioactive 3D. Three-dimensional shapes are popular in spine surgery and with this addition, we now have one of the most extensive biologic portfolios on the market.”
Pioneer Surgical Biologics now offers a full line of synthetic bone grafts as well as human tissue products including machined lateral, traditional lumbar and cervical allograft, human demineralized bone matrix (DBM) bone grafts, as well as bone graft delivery accessories. For more information regarding Pioneer’s Biologics Product offerings, including nanOss Bioactive 3D, please visit the Pio...
